Skip Navigation

Faculty Directory

David Dowdy, MD

  • Associate Professor

Departmental Affiliations

  • Epidemiology (Primary)
    • Division: Infectious Disease Epidemiology

Center & Institute Affiliations

Contact Information

615 N. Wolfe Street
Room E6531
Baltimore, Maryland 21205


TB Modeling and Translational Epi Group:


MD, Johns Hopkins School of Medicine, 2008
PhD, Johns Hopkins Bloomberg School of Public Health, 2008
ScM, Johns Hopkins Bloomberg School of Public Health, 2002


I am a junior investigator in the field of infectious disease epidemiology, and also a practicing general internist.  My interdisciplinary research lies at the nexus of infectious disease modeling, health economics, operational and implementation science, and classical epidemiology.  My primary interests are:

(1) Dynamic modeling and economic evaluation of TB and TB/HIV: My greatest research passion is evaluating the implementation and scale-up of TB and HIV control interventions, especially diagnostic and case-finding strategies.  I combine methods from traditional epidemiology, cost-effectiveness analysis, and epidemic modeling with the aim of answering questions of relevance to patients and policy-makers.  I serve on the steering committee of the Gates Foundation-funded TB-Modeling and Analysis Consortium (TB-MAC) and direct two NIH-funded projects related to modeling the scale-up of TB diagnostic tests.  I currently work with collaborators on projects based in Malawi, South Africa, Uganda, India, Zambia, Brazil, Canada, and the United States. 

(2) Translational epidemiology: I have great interest in creating modeling frameworks that allow decision-makers to translate epidemiological data into effective decisions.  I welcome collaboration from researchers, clinicians, or students having expertise in any field, who hope to create models to translate epidemiological data into meaningful policy, practical, or clinical decisions.

(3) Implementation science: I am interested not only in how interventions operate in idealized settings, but also improving how they are implemented in the real world.  Generally, implementation barriers are greater than theoretical scientific ones; I think it is critical to conduct research that will help us overcome them.

(4) Teaching and mentorship:  These are essential, and often-undervalued, skills in the field of epidemiology.  If our profession is to continue its record of success, I firmly believe that we need to train future leaders how to teach and mentor others, and also to do our best to serve as role models in that regard.

Honors and Awards

Awards since 2008:

2014 Golden Apple Teaching Award (large class)

2013 Advising, Mentoring, and Teaching Recognition Award (AMTRA), JHSPH

2012 B. Frank and Kathleen Polk Assistant Professor of Epidemiology

2012 Young Investigator Prize, International Union Against Tuberculosis and Lung Disease

2011  Tom Evans Teaching Award, Internal Medicine Residency Program, UCSF

2010  Diane Becker Award in Clinical Epidemiology and Prevention, Johns Hopkins GIM Housestaff Research Award

2010  Floyd Rector Clinical Science Research Award, Internal Medicine Residency Program, UCSF

2010  Teaching Excellence Award for Cherished Housestaff (TEACH), UCSF School of Medicine

2009  Julius Krevans Award for Outstanding Housestaff Service, San Francisco General Hospital

2008  Warfield T. Longcope Prize in Clinical Medicine, Johns Hopkins University School of Medicine

2008  David E. Rogers Award for Professionalism, Ethics, & Community, Johns Hopkins University School of Medicine

2008  Alpha Omega Alpha Honor Society

2008  Arthur M. Dannenberg, Jr. Award for Tuberculosis Research

  • infectious diseases
  • tuberculosis
  • HIV
  • epidemiology
  • mathematical modeling
  • implementation science
  • infectious disease dynamics
  • health economics

Publications (1st or senior author) from April to Sept. 2015:

  • Shah M, Risher K, Berry SA, Dowdy DW. The epidemiologic and economic impact ofimproving HIV testing, linkage, and retention in care in the United States. Clin Infect Dis. 2015 Sep 11.  [Epub ahead of print] 

  • Salje H, Andrews JR, Deo S, Satyanarayana S, Sun AY, Pai M, Dowdy DW. The
    importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model. PLoS Med. 2014 Jul 15;11(7):e100167Zwerling AA, Sahu M, Ngwira LG, Khundi M, Harawa T, Corbett EL, Chaisson RE,
    Zwerling AA, Sahu M, Ngwira LG, Khundi M, Harawa T, Corbett EL, Chaisson RE,
    Dowdy DW. Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in
    Sub-Saharan Africa: A Cost-Effectiveness Analysis. J Acquir Immune Defic Syndr.
    2015 Sep 1;70(1):83-90. 
  • Little KM, Pai M, Dowdy DW. Costs and Consequences of Using Interferon-γ
    Release Assays for the Diagnosis of Active Tuberculosis in India. PLoS One. 2015 
    Apr 28;10(4):e0124525. 

    Little KM, Pai M, Dowdy DW. Costs and Consequences of Using Interferon-γRelease Assays for the Diagnosis of Active Tuberculosis in India. PLoS One. 2015 Apr 28;10(4):e0124525. 

  • Johnston JC, Khan FA, Dowdy DW. Reducing relapse in tuberculosis treatment: isit time to reassess WHO treatment guidelines? Int J Tuberc Lung Dis. 2015Jun;19(6):624.